Crystal Structure Prediction

A new service opening up exciting possibilities!

The rapidly increasing scope of applicability of Crystal Structure Prediction (CSP) opens up exciting new possibilities for the risk management of crystal polymorphism. For many pharmaceutical compounds, it is now-a-days possible to computationally determine up to 98% of the crystal structures that may be encountered experimentally! AMS is the only company in the world that has developed the technology to perform predictions with such high level of accuracy.

In collaboration with AMS, Avantium Pharma offers Crystal Structure Prediction as a new service to the pharmaceutical industry.

Get an early warning if a stable polymorph might have been missed experimentally
Obtain 3-D structures of experimentally observed polymorphs without needing more sample
Easily pick up traces of new polymorphs in a mixture
Identify candidate structures that were not yet found experimentally
Target screening experiments and rational design towards crystallizing relevant candidates

The crystal structures of molecules like these are predictable!

Click here for press release Crystal Structure Predicition